Global Information
회사소개 | 문의 | 비교리스트

세계의 의약품 개발 및 임상시험용 인공지능(AI) 시장(2020년)

AI in Drug Development & Clinical Trials - World - 2020

리서치사 Signify Research
발행일 2020년 10월 30일 발행예정 상품 코드 949933
페이지 정보 영문
US $ 6,300 US $ 5,000 ₩ 5,717,000 PDF & Excel (Single User License)
US $ 10,400 US $ 8,000 ₩ 9,147,000 PDF & Excel (Enterprise User License)

세계의 의약품 개발 및 임상시험용 인공지능(AI) 시장(2020년) AI in Drug Development & Clinical Trials - World - 2020
발행일 : 2020년 10월 30일 발행예정 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

아래 내용의 보고서를 제공합니다.

보고서 개요


  • 제품과 최종 시장
  • 시장 성장 촉진요인과 성장 장벽
  • 시장 규모와 성장 예측


  • AI 애플리케이션 시장 분석
  • 첨단 머신러닝과 딥러닝의 영향
  • 차세대 DNA 시퀀싱 및 프로세싱 기술의 영향


  • 주요 벤더의 시장 점유율 추정
  • 주요 벤더의 상세 개요, SWOT 분석
  • 잠재적 파트너와 인수 타겟


2019-2024년 시장 지표

시장 분석 : 주요 지역/국가별

  • 아메리카
    • 미국
    • 캐나다
    • 브라질
    • 멕시코
    • 기타 라틴아메리카
  • 유럽, 중동 및 아프리카
    • 베네룩스
    • 프랑스
    • DACH
    • 이탈리아
    • 북유럽
    • 영국/아일랜드
    • 스페인/포르투갈
    • 동유럽
    • 중동
    • 아프리카
  • 아시아
    • 오세아니아
    • 인도
    • 한국

국가별 시장 분석 : 제품 그룹별

  • 제품 종류
    • 정보 및 질환 모델
    • 의약품 설계 및 최적화
    • 전임상/임상시험
  • 제품 구성요소
    • 소프트웨어
    • 하드웨어
    • 서비스
  • 라이선싱 모델
    • 영구 라이선스
    • 구독 라이선스
    • Fee per Study
    • 파트너십

제품 세분화 : 임상 응용별

  • 종양
  • 신경
  • 감염증
  • 기타/전반

제품 세분화 : 아키텍처별

  • 온프레미스(프라이빗 클라우드 포함)
  • 클라우드(호스티드)
LSH 20.09.23

Report Overview


  • Identify the products and end-markets driving growth
  • Review the market drivers and barriers for growth
  • Quantitative analysis of market size and forecast growth


  • Market analysis for AI applications in information and disease models, drug design & optimisation, preclinical & clinical trials
  • Impact of advanced machine learning and deep learning
  • Influence of next generation DNA sequencing and processing technologies


  • Market share estimates for the leading vendors
  • Detailed profiles of selected vendors, with SWOT analysis for each
  • Identify potential partners and acquisition targets


  • Review go-to-market strategies
  • Analysis and insights to support your strategy and business planning
  • Product pricing and software delivery strategies

Report Features:

  • Expert commentary on the market Trends
  • Primary research method ensures accuracy and reliability
  • Direct access to the lead Analyst
  • Highly data-centric, with numerous segmentations of the market
  • Detailed analysis by product, sales model and application to highlight growth opportunities
  • Robust forecasts driven by proprietary database of hospital infrastructure
  • Report focused on global market coverage with detailed country analysis
  • Actionable, jargon-free analyst insight and opinion

Key issues Addressed:

  • How large is the global market for AI in drug development in terms of revenue and how will this change over the next five years?
  • How does the market break out in terms of applications for information synthesis, drug design and clinical trials?
  • How does the market break out in terms of clinical areas (oncology, neurology, infectious disease, other)?
  • How is the market split between licencing models?
  • What are the main drivers behind each market segment?
  • Who are the leading vendors and what is needed to stay competitive?

Table of Contents

This is the preliminary research scope. The below outlines market splits that are being considered for inclusion in the scope.

Market metrics presented for the period 2019 to 2024.

The report is primarily organised by Product Group, with dedicated chapters for the following:

  • Information & Disease Models (AI based applications to: aggregate and synthesize information, understand mechanisms of disease, establish biomarkers, generate data and models)
  • Drug Design & Optimisation (AI applications to: repurpose existing drugs, generate novel drug candidates, validate and optimise drug candidates, design drugs)
  • Preclinical & Clinical Trials (AI applications to: design preclinical experiments, run preclinical experiments, design clinical trials, recruit for clinical trials, optimise clinical trials, publish data, analyse real world evidence)

The market will be broken down by Geographic Region into the following major regions and countries/subregions:

  • Americas
    • US
    • Canada
    • Brazil
    • Mexico
    • Rest of Latin America
  • EMEA
    • Benelux
    • France
    • DACH
    • Italy
    • Nordics
    • UK/Eire
    • Spain/Portugal
    • E. Europe
    • Middle East
    • Africa
  • Asia
    • Oceania
    • India
    • South Korea

For each country the market is segmented by Product Group into:

  • Product Type
    • Information & Disease Models
    • Drug Design & Optimisation
    • Preclinical & Clinical Trials
  • Product Component
    • Software
    • Hardware
    • Service
  • Licensing Model
    • Perpetual License
    • Subscription License
    • Fee per Study
    • Partnership

Each product is then further segmented by Clinical Application into:

  • Oncology
  • Neurology
  • Infectious Disease
  • Other/General

Each product is then further segmented by Architecture into:

  • On-Premise (inc. private cloud)
  • Cloud (hosted)
Back to Top
전화 문의